Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Essioux

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Plos One|June 12, 2012
CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritisSophine B Krintel, Laurent Essioux, Assaf Wool, et al.
Human Molecular Genetics|May 25, 2002
Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general populationHans Knoblauch, Anja Bauerfeind, Christine Krähenbühl, et al.
Antiviral Therapy|June 27, 2007
Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by saquinavir in combination with atazanavir or lopinavirElisabeth Dam, Sophie Lebel-Binay, Séverine Rochas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 2008
Association of four DNA polymorphisms with acute rejection after kidney transplantationJosep Grinyó, Yves Vanrenterghem, Björn Nashan, et al.
Molecular Cancer Therapeutics|February 2, 2013
Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell linesAngélique Augustin, Jens Lamerz, Hélène Meistermann, et al.
Journal for Immunotherapy of Cancer|November 13, 2024
Correlation of safety and efficacy of atezolizumab therapy across indicationsGonzalo Durán-Pacheco, G Scott Chandler, Vidya Maiya, et al.
Oncotarget|March 15, 2018
Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumabGong Chen, Ya-Chi Chen, Bernhard Reis, et al.
Pharmacogenetics and Genomics|July 21, 2009
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphismFerdi Sombogaard, Ron H N van Schaik, Ron A Mathot, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2013
Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arraysMaziar Assadi, Jens Lamerz, Tiantom Jarutat, et al.
British Journal of Haematology|April 10, 2015
MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemiaHua Zhong, Gong Chen, Lori Jukofsky, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Plos One|June 12, 2012
CD6 and syntaxin binding protein 6 variants and response to tumor necrosis factor alpha inhibitors in Danish patients with rheumatoid arthritisSophine B Krintel, Laurent Essioux, Assaf Wool, et al.
Human Molecular Genetics|May 25, 2002
Common haplotypes in five genes influence genetic variance of LDL and HDL cholesterol in the general populationHans Knoblauch, Anja Bauerfeind, Christine Krähenbühl, et al.
Antiviral Therapy|June 27, 2007
Synergistic inhibition of protease-inhibitor-resistant HIV type 1 by saquinavir in combination with atazanavir or lopinavirElisabeth Dam, Sophie Lebel-Binay, Séverine Rochas, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|May 1, 2008
Association of four DNA polymorphisms with acute rejection after kidney transplantationJosep Grinyó, Yves Vanrenterghem, Björn Nashan, et al.
Molecular Cancer Therapeutics|February 2, 2013
Quantitative chemical proteomics profiling differentiates erlotinib from gefitinib in EGFR wild-type non-small cell lung carcinoma cell linesAngélique Augustin, Jens Lamerz, Hélène Meistermann, et al.
Journal for Immunotherapy of Cancer|November 13, 2024
Correlation of safety and efficacy of atezolizumab therapy across indicationsGonzalo Durán-Pacheco, G Scott Chandler, Vidya Maiya, et al.
Oncotarget|March 15, 2018
Combining expression of GPC3 in tumors and CD16 on NK cells from peripheral blood to identify patients responding to codrituzumabGong Chen, Ya-Chi Chen, Bernhard Reis, et al.
Pharmacogenetics and Genomics|July 21, 2009
Interpatient variability in IMPDH activity in MMF-treated renal transplant patients is correlated with IMPDH type II 3757T > C polymorphismFerdi Sombogaard, Ron H N van Schaik, Ron A Mathot, et al.
Molecular & Cellular Proteomics : MCP|May 9, 2013
Multiple protein analysis of formalin-fixed and paraffin-embedded tissue samples with reverse phase protein arraysMaziar Assadi, Jens Lamerz, Tiantom Jarutat, et al.
British Journal of Haematology|April 10, 2015
MDM2 antagonist clinical response association with a gene expression signature in acute myeloid leukaemiaHua Zhong, Gong Chen, Lori Jukofsky, et al.
Pageof 3